Gupta Nilesh, Liu Jeffrey R, Patel Brijeshkumar, Solomon Deepak E, Vaidya Bhuvaneshwar, Gupta Vivek
Neofluidics LLC, Research and Development Wing San Diego CA 92121.
DS Laboratories, Inc., Research and Development Pompano Beach FL 33064.
Bioeng Transl Med. 2016 Jul 5;1(1):63-81. doi: 10.1002/btm2.10013. eCollection 2016 Mar.
The implementation of microfluidic devices within life sciences has furthered the possibilities of both academic and industrial applications such as rapid genome sequencing, predictive drug studies, and single cell manipulation. In contrast to the preferred two-dimensional cell-based screening, three-dimensional (3D) systems have more in vivo relevance as well as ability to perform as a predictive tool for the success or failure of a drug screening campaign. 3D cell culture has shown an adaptive response to the recent advancements in microfluidic technologies which has allowed better control over spheroid sizes and subsequent drug screening studies. In this review, we highlight the most significant developments in the field of microfluidic 3D culture over the past half-decade with a special focus on their benefits and challenges down the lane. With the newer technologies emerging, implementation of microfluidic 3D culture systems into the drug discovery pipeline is right around the bend.
微流控设备在生命科学领域的应用拓展了学术和工业应用的可能性,如快速基因组测序、预测性药物研究和单细胞操作。与首选的基于二维细胞的筛选方法不同,三维(3D)系统与体内情况更相关,并且能够作为药物筛选活动成败的预测工具。3D细胞培养已显示出对微流控技术最新进展的适应性反应,这使得能够更好地控制球体大小以及后续的药物筛选研究。在本综述中,我们重点介绍了过去五年中微流控3D培养领域的最重要进展,并特别关注其未来的优势和挑战。随着新技术的不断涌现,将微流控3D培养系统应用于药物发现流程已指日可待。